Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cellectar Biosciences, Inc. | President and CEO, Director | Stock option (right to buy) | 900K | Jun 14, 2024 | Direct | ||
Cellectar Biosciences, Inc. | President and CEO, Director | Common Stock | 49.2K | Dec 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLRB | Cellectar Biosciences, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | President and CEO, Director |
CLRB | Cellectar Biosciences, Inc. | Jun 23, 2023 | 2 | $0 | 4 | Dec 12, 2023 | President and CEO, Director |
CLRB | Cellectar Biosciences, Inc. | Jan 17, 2023 | 1 | $0 | 4 | Jan 18, 2023 | President and CEO, Director |
CLRB | Cellectar Biosciences, Inc. | Jan 25, 2022 | 1 | $0 | 4 | Jan 27, 2022 | President and CEO, Director |